Share Price and Basic Stock Data
Last Updated: November 28, 2025, 7:45 am
| PEG Ratio | 1.19 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
BLB Ltd operates in the Finance & Investments sector, with its stock currently priced at ₹16.6 and a market capitalization of ₹86.1 Cr. The company has shown fluctuating sales over the past quarters, with a notable increase in revenue during the March 2024 quarter, which surged to ₹205 Cr, followed by ₹236 Cr in June 2024. However, sales decreased to ₹25 Cr by September 2023, showcasing volatility in revenue generation. Over the trailing twelve months (TTM), the company reported sales of ₹527 Cr. This indicates a recovery trend as compared to the previous fiscal year where sales stood at ₹220 Cr for March 2023. The overall operational performance reflects a need for strategic adjustments to stabilize revenue amidst varying market conditions.
Profitability and Efficiency Metrics
BLB Ltd’s profitability metrics reveal a challenging landscape. The company recorded a net profit of ₹13 Cr, translating to a P/E ratio of 6.88, which is relatively low compared to industry averages. The operating profit margin (OPM) stood at 26%, indicating decent operational efficiency; however, it fluctuated significantly in recent quarters, with a high of 26% in June 2025 and a low of -8% in December 2024. Notably, the return on equity (ROE) is at 3.99%, and the return on capital employed (ROCE) is at 6.58%, both of which are on the lower end of the spectrum for financial services firms, indicating potential inefficiencies in capital deployment. The interest coverage ratio (ICR) is alarmingly low at 0.01x, suggesting significant challenges in covering interest expenses with current earnings.
Balance Sheet Strength and Financial Ratios
From a balance sheet perspective, BLB Ltd appears to be in a stable position with no borrowings reported, which enhances its financial health. The company’s reserves have increased to ₹112 Cr, reflecting a solid buffer against operational volatility. The price-to-book value ratio stands at 0.30x, indicating that the stock is trading at a significant discount to its book value, which may attract value investors. However, the company’s cash conversion cycle is concerning at 13 days, indicating a relatively quick turnaround in converting investments into cash, yet the efficiency in managing working capital remains a focus area. Financial ratios such as the current ratio and quick ratio indicate adequate liquidity, but the overall return metrics suggest that the firm must optimize its asset utilization to improve shareholder value.
Shareholding Pattern and Investor Confidence
The shareholding structure of BLB Ltd reveals a shift in investor confidence, particularly among promoters and institutional investors. Promoter holdings have decreased from 70.45% in December 2022 to 41.00% by March 2025, signifying a dilution of control and possibly a strategic shift. Foreign Institutional Investors (FIIs) have a minimal stake of 0.11%, reflecting limited interest from foreign investors. Public ownership has risen to 58.89%, indicating a growing retail investor base, which may suggest confidence in the company’s long-term prospects. The number of shareholders has also increased from 8,041 in December 2022 to 13,766 by March 2025, which is a positive sign for liquidity and market participation. However, the heavy reliance on public investors could pose risks if sentiment shifts suddenly.
Outlook, Risks, and Final Insight
Looking ahead, BLB Ltd faces both opportunities and challenges. The significant rise in sales in recent quarters indicates potential for recovery, but the volatility in profitability metrics highlights underlying operational inefficiencies that need addressing. Risks include the low interest coverage ratio and declining promoter shareholding, which may affect market perceptions and investor confidence. A focus on improving capital efficiency and stabilizing revenue streams will be crucial. If the company can effectively manage its operational challenges, it may enhance its attractiveness to both institutional and retail investors, fostering a more robust investment environment. However, failure to do so could lead to further declines in profitability and market position, necessitating strategic pivots.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of BLB Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Monarch Networth Capital Ltd | 2,441 Cr. | 308 | 484/280 | 15.7 | 111 | 0.33 % | 33.3 % | 26.2 % | 10.0 |
| Monotype India Ltd | 35.2 Cr. | 0.50 | 2.42/0.46 | 4.87 | 0.03 | 0.00 % | 286 % | % | 1.00 |
| Multipurpose Trading & Agencies Ltd | 4.96 Cr. | 10.0 | 12.6/8.25 | 9.25 | 0.00 % | 3.68 % | 3.38 % | 10.0 | |
| Munoth Financial Services Ltd | 24.8 Cr. | 48.4 | 72.0/47.6 | 19.9 | 0.00 % | 2.41 % | 3.38 % | 10.0 | |
| Naperol Investments Ltd | 466 Cr. | 810 | 1,433/772 | 48.4 | 2,055 | 1.10 % | 1.06 % | 0.95 % | 10.0 |
| Industry Average | 7,061.43 Cr | 1,444.02 | 75.87 | 3,872.22 | 0.35% | 21.83% | 14.30% | 7.26 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 20 | 41 | 81 | 77 | 39 | 25 | 44 | 205 | 236 | 171 | 73 | 59 | 56 |
| Expenses | 18 | 38 | 80 | 75 | 36 | 23 | 42 | 208 | 224 | 167 | 80 | 63 | 42 |
| Operating Profit | 2 | 3 | 1 | 2 | 3 | 2 | 2 | -3 | 12 | 4 | -6 | -4 | 15 |
| OPM % | 10% | 7% | 2% | 3% | 9% | 8% | 5% | -1% | 5% | 2% | -8% | -6% | 26% |
| Other Income | -0 | 0 | 0 | 1 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 1 | 3 | 1 | 3 | 3 | 2 | 2 | -3 | 12 | 4 | -6 | -4 | 15 |
| Tax % | 21% | 25% | 47% | 16% | 23% | 27% | 26% | -24% | 28% | 17% | -24% | -24% | 23% |
| Net Profit | 1 | 2 | 1 | 2 | 2 | 1 | 1 | -2 | 9 | 3 | -5 | -3 | 11 |
| EPS in Rs | 0.22 | 0.38 | 0.11 | 0.43 | 0.43 | 0.23 | 0.28 | -0.45 | 1.64 | 0.58 | -0.93 | -0.57 | 2.17 |
Last Updated: August 20, 2025, 12:45 pm
Below is a detailed analysis of the quarterly data for BLB Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 56.00 Cr.. The value appears to be declining and may need further review. It has decreased from 59.00 Cr. (Mar 2025) to 56.00 Cr., marking a decrease of 3.00 Cr..
- For Expenses, as of Jun 2025, the value is 42.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 63.00 Cr. (Mar 2025) to 42.00 Cr., marking a decrease of 21.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 15.00 Cr.. The value appears strong and on an upward trend. It has increased from -4.00 Cr. (Mar 2025) to 15.00 Cr., marking an increase of 19.00 Cr..
- For OPM %, as of Jun 2025, the value is 26.00%. The value appears strong and on an upward trend. It has increased from -6.00% (Mar 2025) to 26.00%, marking an increase of 32.00%.
- For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 15.00 Cr.. The value appears strong and on an upward trend. It has increased from -4.00 Cr. (Mar 2025) to 15.00 Cr., marking an increase of 19.00 Cr..
- For Tax %, as of Jun 2025, the value is 23.00%. The value appears to be increasing, which may not be favorable. It has increased from -24.00% (Mar 2025) to 23.00%, marking an increase of 47.00%.
- For Net Profit, as of Jun 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from -3.00 Cr. (Mar 2025) to 11.00 Cr., marking an increase of 14.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 2.17. The value appears strong and on an upward trend. It has increased from -0.57 (Mar 2025) to 2.17, marking an increase of 2.74.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 5:38 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 129 | 301 | 62 | 119 | 518 | 194 | 203 | 537 | 355 | 220 | 314 | 539 | 527 |
| Expenses | 132 | 299 | 59 | 117 | 518 | 196 | 200 | 532 | 343 | 211 | 308 | 533 | 513 |
| Operating Profit | -4 | 1 | 3 | 3 | 0 | -2 | 2 | 5 | 13 | 9 | 7 | 7 | 15 |
| OPM % | -3% | 0% | 4% | 2% | 0% | -1% | 1% | 1% | 4% | 4% | 2% | 1% | 3% |
| Other Income | 0 | 0 | -0 | -0 | -0 | 1 | -12 | 0 | 0 | 0 | -2 | 0 | 2 |
| Interest | 0 | 1 | 1 | 1 | 5 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -4 | 0 | 1 | 1 | -6 | -3 | -12 | 4 | 11 | 8 | 3 | 5 | 16 |
| Tax % | -31% | -168% | -1% | 64% | -8% | 41% | -32% | 72% | 17% | 24% | 26% | 27% | |
| Net Profit | -3 | 1 | 1 | 0 | -5 | -4 | -8 | 1 | 9 | 6 | 3 | 4 | 13 |
| EPS in Rs | -0.57 | 0.14 | 0.14 | 0.06 | -0.98 | -0.77 | -1.52 | 0.21 | 1.78 | 1.14 | 0.49 | 0.73 | 2.36 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 133.33% | 0.00% | -100.00% | 20.00% | -100.00% | 112.50% | 800.00% | -33.33% | -50.00% | 33.33% |
| Change in YoY Net Profit Growth (%) | 0.00% | -133.33% | -100.00% | 120.00% | -120.00% | 212.50% | 687.50% | -833.33% | -16.67% | 83.33% |
BLB Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 22% |
| 3 Years: | 15% |
| TTM: | -30% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | -3% |
| 3 Years: | -26% |
| TTM: | -26% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 21% |
| 3 Years: | -11% |
| 1 Year: | -16% |
| Return on Equity | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 5% |
| 3 Years: | 5% |
| Last Year: | 4% |
Last Updated: September 5, 2025, 1:05 am
Balance Sheet
Last Updated: November 9, 2025, 1:46 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves | 108 | 95 | 94 | 91 | 84 | 80 | 72 | 73 | 82 | 88 | 91 | 92 | 112 |
| Borrowings | 3 | 7 | 16 | 7 | 13 | 13 | 16 | 2 | 4 | 4 | 0 | 0 | 0 |
| Other Liabilities | 1 | 3 | 1 | 1 | 2 | 1 | 10 | 1 | 2 | 0 | 2 | 1 | 5 |
| Total Liabilities | 118 | 109 | 116 | 104 | 104 | 99 | 102 | 81 | 94 | 98 | 98 | 98 | 123 |
| Fixed Assets | 5 | 4 | 4 | 16 | 19 | 16 | 12 | 11 | 12 | 11 | 4 | 4 | 4 |
| CWIP | 6 | 6 | 8 | 6 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 26 | 26 | 28 | 21 | 8 | 2 | 1 | 2 | 1 | 0 | 0 | 11 | 3 |
| Other Assets | 80 | 72 | 76 | 61 | 72 | 80 | 89 | 68 | 81 | 86 | 94 | 83 | 116 |
| Total Assets | 118 | 109 | 116 | 104 | 104 | 99 | 102 | 81 | 94 | 98 | 98 | 98 | 123 |
Below is a detailed analysis of the balance sheet data for BLB Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 5.00 Cr..
- For Reserves, as of Sep 2025, the value is 112.00 Cr.. The value appears strong and on an upward trend. It has increased from 92.00 Cr. (Mar 2025) to 112.00 Cr., marking an increase of 20.00 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 5.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.00 Cr. (Mar 2025) to 5.00 Cr., marking an increase of 4.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 123.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 98.00 Cr. (Mar 2025) to 123.00 Cr., marking an increase of 25.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 11.00 Cr. (Mar 2025) to 3.00 Cr., marking a decrease of 8.00 Cr..
- For Other Assets, as of Sep 2025, the value is 116.00 Cr.. The value appears strong and on an upward trend. It has increased from 83.00 Cr. (Mar 2025) to 116.00 Cr., marking an increase of 33.00 Cr..
- For Total Assets, as of Sep 2025, the value is 123.00 Cr.. The value appears strong and on an upward trend. It has increased from 98.00 Cr. (Mar 2025) to 123.00 Cr., marking an increase of 25.00 Cr..
Notably, the Reserves (112.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -7.00 | -6.00 | -13.00 | -4.00 | -13.00 | -15.00 | -14.00 | 3.00 | 9.00 | 5.00 | 7.00 | 7.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 25 | 11 | 52 | 27 | 6 | 16 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory Days | 16 | 3 | 0 | 16 | 13 | 2 | 8 | 4 | 11 | 34 | 36 | 13 |
| Days Payable | 1 | 2 | 2 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Cash Conversion Cycle | 40 | 11 | 50 | 43 | 19 | 18 | 7 | 4 | 11 | 34 | 36 | 13 |
| Working Capital Days | 76 | 27 | 89 | 123 | 23 | 61 | 28 | 21 | 42 | 99 | 81 | 43 |
| ROCE % | -3% | 1% | 2% | 2% | 0% | -2% | 3% | 6% | 14% | 9% | 7% | 7% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 18 | Mar 17 | Mar 16 | Mar 15 | Mar 14 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | -1.01 | 0.24 | 0.30 | 0.37 | -0.39 |
| Diluted EPS (Rs.) | -1.01 | 0.24 | 0.30 | 0.37 | -0.39 |
| Cash EPS (Rs.) | -0.88 | 0.34 | 0.48 | 0.54 | -0.28 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 16.92 | 17.94 | 19.79 | 19.71 | 21.96 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 16.92 | 17.94 | 19.79 | 19.71 | 21.96 |
| Revenue From Operations / Share (Rs.) | 97.75 | 87.69 | 54.20 | 110.00 | 65.11 |
| PBDIT / Share (Rs.) | 0.01 | 1.55 | 1.39 | 1.15 | 0.08 |
| PBIT / Share (Rs.) | -0.08 | 1.44 | 1.20 | 0.97 | -0.02 |
| PBT / Share (Rs.) | -1.07 | 0.22 | 0.35 | 0.40 | -0.53 |
| Net Profit / Share (Rs.) | -0.98 | 0.23 | 0.29 | 0.36 | -0.39 |
| NP After MI And SOA / Share (Rs.) | -0.98 | 0.23 | 0.29 | 0.36 | -0.39 |
| PBDIT Margin (%) | 0.00 | 1.76 | 2.56 | 1.04 | 0.13 |
| PBIT Margin (%) | -0.08 | 1.64 | 2.21 | 0.88 | -0.03 |
| PBT Margin (%) | -1.09 | 0.26 | 0.65 | 0.36 | -0.81 |
| Net Profit Margin (%) | -1.00 | 0.27 | 0.55 | 0.33 | -0.60 |
| NP After MI And SOA Margin (%) | -1.00 | 0.27 | 0.55 | 0.33 | -0.60 |
| Return on Networth / Equity (%) | -5.81 | 1.33 | 1.51 | 1.87 | -1.78 |
| Return on Capital Employeed (%) | -0.51 | 8.02 | 6.05 | 4.95 | -0.09 |
| Return On Assets (%) | -4.98 | 0.67 | 1.00 | 1.25 | -1.23 |
| Total Debt / Equity (X) | 0.14 | 0.87 | 0.47 | 0.43 | 0.41 |
| Asset Turnover Ratio (%) | 3.56 | 0.88 | 0.42 | 2.14 | 0.85 |
| Current Ratio (X) | 2.98 | 1.40 | 1.68 | 1.67 | 1.68 |
| Quick Ratio (X) | 1.77 | 0.74 | 1.45 | 1.33 | 1.18 |
| Interest Coverage Ratio (X) | 0.01 | 1.28 | 1.51 | 2.01 | 0.16 |
| Interest Coverage Ratio (Post Tax) (X) | 0.00 | 1.20 | 1.25 | 1.64 | 0.22 |
| Enterprise Value (Cr.) | 34.78 | 119.94 | 27.75 | 32.98 | 35.07 |
| EV / Net Operating Revenue (X) | 0.06 | 0.25 | 0.09 | 0.05 | 0.10 |
| EV / EBITDA (X) | 903.43 | 14.67 | 3.78 | 5.41 | 76.95 |
| MarketCap / Net Operating Revenue (X) | 0.05 | 0.08 | 0.05 | 0.03 | 0.04 |
| Price / BV (X) | 0.30 | 0.41 | 0.16 | 0.18 | 0.14 |
| Price / Net Operating Revenue (X) | 0.05 | 0.08 | 0.05 | 0.03 | 0.04 |
| EarningsYield | -0.19 | 0.03 | 0.09 | 0.10 | -0.12 |
After reviewing the key financial ratios for BLB Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 18, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 17) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 18, the value is -1.01. This value is below the healthy minimum of 5. It has decreased from 0.24 (Mar 17) to -1.01, marking a decrease of 1.25.
- For Diluted EPS (Rs.), as of Mar 18, the value is -1.01. This value is below the healthy minimum of 5. It has decreased from 0.24 (Mar 17) to -1.01, marking a decrease of 1.25.
- For Cash EPS (Rs.), as of Mar 18, the value is -0.88. This value is below the healthy minimum of 3. It has decreased from 0.34 (Mar 17) to -0.88, marking a decrease of 1.22.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 18, the value is 16.92. It has decreased from 17.94 (Mar 17) to 16.92, marking a decrease of 1.02.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 18, the value is 16.92. It has decreased from 17.94 (Mar 17) to 16.92, marking a decrease of 1.02.
- For Revenue From Operations / Share (Rs.), as of Mar 18, the value is 97.75. It has increased from 87.69 (Mar 17) to 97.75, marking an increase of 10.06.
- For PBDIT / Share (Rs.), as of Mar 18, the value is 0.01. This value is below the healthy minimum of 2. It has decreased from 1.55 (Mar 17) to 0.01, marking a decrease of 1.54.
- For PBIT / Share (Rs.), as of Mar 18, the value is -0.08. This value is below the healthy minimum of 0. It has decreased from 1.44 (Mar 17) to -0.08, marking a decrease of 1.52.
- For PBT / Share (Rs.), as of Mar 18, the value is -1.07. This value is below the healthy minimum of 0. It has decreased from 0.22 (Mar 17) to -1.07, marking a decrease of 1.29.
- For Net Profit / Share (Rs.), as of Mar 18, the value is -0.98. This value is below the healthy minimum of 2. It has decreased from 0.23 (Mar 17) to -0.98, marking a decrease of 1.21.
- For NP After MI And SOA / Share (Rs.), as of Mar 18, the value is -0.98. This value is below the healthy minimum of 2. It has decreased from 0.23 (Mar 17) to -0.98, marking a decrease of 1.21.
- For PBDIT Margin (%), as of Mar 18, the value is 0.00. This value is below the healthy minimum of 10. It has decreased from 1.76 (Mar 17) to 0.00, marking a decrease of 1.76.
- For PBIT Margin (%), as of Mar 18, the value is -0.08. This value is below the healthy minimum of 10. It has decreased from 1.64 (Mar 17) to -0.08, marking a decrease of 1.72.
- For PBT Margin (%), as of Mar 18, the value is -1.09. This value is below the healthy minimum of 10. It has decreased from 0.26 (Mar 17) to -1.09, marking a decrease of 1.35.
- For Net Profit Margin (%), as of Mar 18, the value is -1.00. This value is below the healthy minimum of 5. It has decreased from 0.27 (Mar 17) to -1.00, marking a decrease of 1.27.
- For NP After MI And SOA Margin (%), as of Mar 18, the value is -1.00. This value is below the healthy minimum of 8. It has decreased from 0.27 (Mar 17) to -1.00, marking a decrease of 1.27.
- For Return on Networth / Equity (%), as of Mar 18, the value is -5.81. This value is below the healthy minimum of 15. It has decreased from 1.33 (Mar 17) to -5.81, marking a decrease of 7.14.
- For Return on Capital Employeed (%), as of Mar 18, the value is -0.51. This value is below the healthy minimum of 10. It has decreased from 8.02 (Mar 17) to -0.51, marking a decrease of 8.53.
- For Return On Assets (%), as of Mar 18, the value is -4.98. This value is below the healthy minimum of 5. It has decreased from 0.67 (Mar 17) to -4.98, marking a decrease of 5.65.
- For Total Debt / Equity (X), as of Mar 18, the value is 0.14. This value is within the healthy range. It has decreased from 0.87 (Mar 17) to 0.14, marking a decrease of 0.73.
- For Asset Turnover Ratio (%), as of Mar 18, the value is 3.56. It has increased from 0.88 (Mar 17) to 3.56, marking an increase of 2.68.
- For Current Ratio (X), as of Mar 18, the value is 2.98. This value is within the healthy range. It has increased from 1.40 (Mar 17) to 2.98, marking an increase of 1.58.
- For Quick Ratio (X), as of Mar 18, the value is 1.77. This value is within the healthy range. It has increased from 0.74 (Mar 17) to 1.77, marking an increase of 1.03.
- For Interest Coverage Ratio (X), as of Mar 18, the value is 0.01. This value is below the healthy minimum of 3. It has decreased from 1.28 (Mar 17) to 0.01, marking a decrease of 1.27.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 18, the value is 0.00. This value is below the healthy minimum of 3. It has decreased from 1.20 (Mar 17) to 0.00, marking a decrease of 1.20.
- For Enterprise Value (Cr.), as of Mar 18, the value is 34.78. It has decreased from 119.94 (Mar 17) to 34.78, marking a decrease of 85.16.
- For EV / Net Operating Revenue (X), as of Mar 18, the value is 0.06. This value is below the healthy minimum of 1. It has decreased from 0.25 (Mar 17) to 0.06, marking a decrease of 0.19.
- For EV / EBITDA (X), as of Mar 18, the value is 903.43. This value exceeds the healthy maximum of 15. It has increased from 14.67 (Mar 17) to 903.43, marking an increase of 888.76.
- For MarketCap / Net Operating Revenue (X), as of Mar 18, the value is 0.05. This value is below the healthy minimum of 1. It has decreased from 0.08 (Mar 17) to 0.05, marking a decrease of 0.03.
- For Price / BV (X), as of Mar 18, the value is 0.30. This value is below the healthy minimum of 1. It has decreased from 0.41 (Mar 17) to 0.30, marking a decrease of 0.11.
- For Price / Net Operating Revenue (X), as of Mar 18, the value is 0.05. This value is below the healthy minimum of 1. It has decreased from 0.08 (Mar 17) to 0.05, marking a decrease of 0.03.
- For EarningsYield, as of Mar 18, the value is -0.19. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 17) to -0.19, marking a decrease of 0.22.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in BLB Ltd:
- Net Profit Margin: -1%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -0.51% (Industry Average ROCE: 21.52%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -5.81% (Industry Average ROE: 13.2%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.77
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 6.88 (Industry average Stock P/E: 47.22)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.14
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -1%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Finance & Investments | H.No. 4760-61/23, 3rd Floor, Ansari Road, New Delhi Delhi 110002 | infoblb@blblimited.com http://www.blblimited.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Brij Rattan Bagri | Chairman & Managing Director |
| Mr. Anshul Mehra | Executive Director |
| Mrs. Anita Sharma | Independent Director |
| Mr. Gaurav Gupta | Independent Director |
| Mr. Deepak Sethi | Independent Director |
| Mr. Deepak Shrivastava | Independent Director |
FAQ
What is the intrinsic value of BLB Ltd?
BLB Ltd's intrinsic value (as of 28 November 2025) is 4.97 which is 70.06% lower the current market price of 16.60, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 86.1 Cr. market cap, FY2025-2026 high/low of 25.0/12.4, reserves of ₹112 Cr, and liabilities of 123 Cr.
What is the Market Cap of BLB Ltd?
The Market Cap of BLB Ltd is 86.1 Cr..
What is the current Stock Price of BLB Ltd as on 28 November 2025?
The current stock price of BLB Ltd as on 28 November 2025 is 16.6.
What is the High / Low of BLB Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of BLB Ltd stocks is 25.0/12.4.
What is the Stock P/E of BLB Ltd?
The Stock P/E of BLB Ltd is 6.88.
What is the Book Value of BLB Ltd?
The Book Value of BLB Ltd is 22.2.
What is the Dividend Yield of BLB Ltd?
The Dividend Yield of BLB Ltd is 0.00 %.
What is the ROCE of BLB Ltd?
The ROCE of BLB Ltd is 6.58 %.
What is the ROE of BLB Ltd?
The ROE of BLB Ltd is 3.99 %.
What is the Face Value of BLB Ltd?
The Face Value of BLB Ltd is 1.00.